Alport Connect 2025 Meeting

Published on 19/06/2025

19-20 July, 2025
Chicago, IL

ENYO Pharma is sponsoring and will attend Alport Connect 2025 organized by the American Alport Syndrome Foundation (ASF), the Alport syndrome patient-led non-profit organization in the US.

ENYO Pharma will meet patients and their families to present its ongoing Phase 2 “ALPESTRIA-1” clinical study with Vonafexor in Alport syndrome patients.

https://alportsyndrome.org/for-patients/alport-connect/

Read next in 'Events'

• BIO International Convention
• Alport Connect 2025, la rencontre annuelle américaine avec les patients atteints du syndrome d’Alport
• BIO International Convention
• 7ème CKD Drug Development Summit
• 7th CKD Summit – Chronic Kidney Disease Drug Development